Patent claims for two human genes declared invalid by US court
This article was originally published in RAJ Devices
Executive Summary
A US federal district court has ruled that certain patent claims for two human genes – BRCA1 and BRCA2, which are associated with breast and ovarian cancer – are invalid1.